Multimodal Neuroimaging Attention-Based architecture for Cognitive Decline Prediction

The early detection of Alzheimer's Disease is imperative to ensure early treatment and improve patient outcomes. There has consequently been extenstive research into detecting AD and its intermediate phase, mild cognitive impairment (MCI). However, there is very small literature in predicting the conversion to AD and MCI from normal cognitive condition. Recently, multiple studies have applied convolutional neural networks (CNN) which integrate Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) to classify MCI and AD. However, in these works, the fusion of MRI and PET features are simply achieved through concatenation, resulting in a lack of cross-modal interactions. In this paper, we propose a novel multimodal neuroimaging attention-based CNN architecture, MNA-net, to predict whether cognitively normal (CN) individuals will develop MCI or AD within a period of 10 years. To address the lack of interactions across neuroimaging modalities seen in previous works, MNA-net utilises attention mechanisms to form shared representations of the MRI and PET images. The proposed MNA-net is tested in OASIS-3 dataset and is able to predict CN individuals who converted to MCI or AD with an accuracy of 83%, true negative rate of 80%, and true positive rate of 86%. The new state of the art results improved by 5% and 10% for accuracy and true negative rate by the use of attention mechanism. These results demonstrate the potential of the proposed model to predict cognitive impairment and attention based mechanisms in the fusion of different neuroimaging modalities to improve the prediction of cognitive decline.